The semaglutide pen looks like an insulin pen, but it isn't one. Here's what the Anvisa approval covers and who a prescriber might consider in Brazil.
If you've scrolled past a photo of a semaglutide pen lately, you're not alone. Semaglutide pens look a lot like insulin pens, and that resemblance leads many adults in Brazil to wonder whether the pen could fit their situation. Let's sort out what the Anvisa approval actually covers and who a prescriber might consider.
Why the pen looks like an insulin pen but isn't one
The format feels familiar: a pre-filled pen, a dose selector, and a small needle that gets replaced for each dose. The active ingredient, though, is semaglutide, a GLP-1 receptor agonist. It is not insulin. The two work through different pathways in the body, which is one reason the question of who should use them is different.
In general terms, these pens are injected once a week under the skin. The exact schedule, starting dose, and dose increases are written in the bula, the official leaflet that comes with the product. Confirm them there and with your prescriber instead of copying a routine you saw online.
Read the labels closely. Pens that look alike can hold different products. Check the drug name on the box and on the pen itself. If the name doesn't match your prescription, stop and ask a pharmacist or your doctor before injecting anything. Also remember that oral semaglutide comes as a tablet. That is a separate product with its own bula.
What the Anvisa approval actually covers
You may come across several product names online, including Ozempic and Wegovy. Don't assume they are interchangeable. Each product's approved use is written in its own bula. As a general summary, one is associated with type 2 diabetes and the other with chronic weight management, but check the exact wording for the product in your hands rather than relying on this overview.
Approval is never a general permission to use semaglutide for weight loss. It ties the medicine to a specific indication, age group, and dose range. If you're comparing options, read what each bula says about its purpose instead of assuming one covers the other.
Your two primary sources are the Anvisa medication consultation portal and the official bula. Match the registration number on your box against the portal, and read the approved indication word for word.
Who may be considered for the type 2 diabetes indication
In general, the diabetes indication considers adults with type 2 diabetes whose blood sugar isn't well controlled despite diet, exercise, and other glucose-lowering medicines. The Sociedade Brasileira de Diabetes (SBD) discusses GLP-1 agents in its guidelines, and the bula describes the approved use. Check both for current wording.
A prescriber usually looks at HbA1c, a test that reflects average blood sugar over the previous few months. They also consider treatments you've already tried, such as metformin, and your cardiovascular risk. The decision is individual. Two people with similar HbA1c results can get different recommendations depending on the rest of their health picture.
Semaglutide is not a substitute for insulin. If you already depend on insulin, don't reduce or stop it because a new medicine is being discussed. Any change to insulin or other diabetes medicines needs medical direction.
Who may be considered for the weight management indication
The weight management indication is for adults with obesity, but the exact eligibility criteria, including BMI cutoffs and any weight-related health conditions, are written in the Brazilian bula. Read those criteria there, because labels from other countries may differ from what Anvisa approved.
The label usually pairs the medicine with a reduced-calorie diet and more physical activity. Your prescriber will likely ask what you've already tried for lifestyle change, for how long, and with what results. Medication is meant to support that foundation, not replace it.
This product isn't for everyone who wants to lose a few kilos for appearance. Cosmetic weight loss without a medical indication falls outside the label. If you want a plain-language walkthrough of how these criteria come up in a consultation, the OzemBlog homepage is a good place to start.
Who should avoid it or needs extra caution
The bula lists contraindications that rule out use. The main ones include a personal or family history of medullary thyroid carcinoma, a history of multiple endocrine neoplasia type 2 (MEN 2), and known hypersensitivity to any ingredient. If any of these apply to you or your family, tell your prescriber before anything else.
Other conditions call for closer medical review rather than automatic exclusion. These include a history of pancreatitis, gastroparesis or other severe digestive disease, significant kidney problems, diabetic retinopathy, and gallbladder disease. Mention all of them, even the ones that seem unrelated.
Pregnancy and breastfeeding need careful planning. The bula gives guidance on use during pregnancy and on how far ahead of a planned pregnancy the medicine should be stopped. That timing is product-specific and belongs to the label and your prescriber, not to a general rule you can apply yourself. Don't adjust doses or stop without talking to your prescriber first.
Some medicines interact in important ways. Insulin and sulfonylureas can raise the risk of low blood sugar when combined with semaglutide, so your prescriber may adjust them. Bring a complete list of everything you take, including supplements and over-the-counter products. The bula describes common side effects, so read that section and ask about anything that worries you.
Questions to bring to the first appointment and what the prescriber checks
A short list makes the visit more useful. Ask which indication fits your case, which tests you need before starting, what the monitoring plan looks like, and what happens if you stop. It also helps to ask how the dose changes over time.
The clinician may review HbA1c or other glucose tests, kidney function, your personal and family medical history (especially any history of thyroid cancer), current medications, and your weight history. Bring any previous results you have.
Cost and access in Brazil vary a lot. Whether a product appears on SUS lists, and whether a private health plan covers it, depends on the specific product and indication. Out-of-pocket prices also differ between pharmacies and presentations, and this post can't quote current prices. Coverage status changes over time, so check SUS listings, ANS guidance, and Conitec assessments directly. If you want general background on how access usually works before that visit, OzemBlog can help you get oriented, and naming the exact brand you've read about makes it easier for your clinician to answer your questions.
Common misunderstandings and when to call the doctor
The first misunderstanding is that approval means the medicine is right for anyone who asks. It doesn't. Approval defines the conditions of use, and the prescriber decides whether your situation fits those conditions.
The second is that an official-looking box guarantees a safe seller. Packaging can be copied. Check the product on the Anvisa registry and compare it with the bula details covered above. Buying from unverified sources carries real risk.
Contact a doctor promptly if you have severe abdominal pain that doesn't ease, persistent vomiting, swelling of the face, lips, or throat, a lump or swelling in the neck, or symptoms of low blood sugar such as shakiness, sweating, or confusion. Seek care too if vomiting or diarrhea leaves you unable to keep fluids down. The bula is the authoritative list of warning signs, so read that section as well.
Semaglutide may help some people with glucose control or weight management, but it is not a cure. Benefits and side effects should be discussed with a qualified professional who knows your full history. OzemBlog can help you prepare for those conversations, but it doesn't replace them.
FAQ
Is the semaglutide pen the same as an insulin pen?
No. The device looks similar, but semaglutide is a GLP-1 receptor agonist, not insulin. Always check the drug name on the box and the pen.
Does Anvisa approval mean I can use semaglutide for weight loss?
Not automatically. Approval is tied to a specific indication, age group, and dose range in the bula. Only the product approved for weight management, used under the conditions in its label, fits that purpose.
Is the oral semaglutide tablet the same product as the pen?
No. The tablet is a separate product with its own bula, indications, and instructions, so information about one doesn't automatically apply to the other.
What should I do if I'm planning a pregnancy?
Talk to your prescriber before trying to conceive. The bula explains the timing for stopping the medicine before a planned pregnancy, and you shouldn't change your plan on your own.
Sources
Disclaimer: This content is for informational purposes only and does not replace professional medical advice. Always consult your doctor before starting, changing or stopping any treatment.
Ozempro — Monitor GLP-1
Never miss a dose and track everything
Injection reminders, a dose history and a side-effects diary — all organized to bring to your appointment.
or download the app
